We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UONE:NASDAQUrban One, Inc. Analysis

Data as of 2026-06-09 - not real-time

$5.88

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Urban One, Inc. (UONE) is trading at $5.88, which sits below its 20‑day (≈$6.13) and 50‑day (≈$6.20) simple moving averages, confirming a short‑term bearish price action. The RSI of 44.8 suggests the stock is not yet oversold, while the MACD line (+$0.022) crosses above its signal, offering a faint bullish hint amid the broader downtrend. Volatility is extreme at 148% over the past 30 days and a beta of ~1.5 signals heightened sensitivity to market swings, amplifying risk for investors. Fundamentally, the company posted a Q1 loss of $3.1 M, revenue fell 15.8% YoY to $77.7 M, and profit margins remain deeply negative, with operating cash flow at zero. Debt is a critical concern: total debt of $479 M versus a market cap of only $26.6 M yields a debt‑to‑equity ratio over 1,700%, dwarfing the modest book value per share of $5.53. On the positive side, the firm trimmed roughly $60 M of debt this quarter, bringing total gross debt to just over $300 M, and announced accretive M&A activity, which helped the stock climb 3% post‑earnings.
Given the low price‑to‑book (≈1.06) and ultra‑low price‑to‑sales (≈0.07) multiples, the market appears to price UONE at a discount to its net assets, yet the combination of declining earnings, high leverage, and volatile trading dynamics suggests that any upside is speculative and contingent on a successful turnaround of cash flow and debt management.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term SMAs indicating bearish bias
  • MACD bullish crossover offering limited upside
  • Decreasing volume and high volatility heightening short‑term risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Debt reduction and announced accretive acquisitions
  • Persistently negative earnings and cash flow
  • Low valuation multiples but uncertain path to profitability

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Extreme leverage (debt‑to‑equity > 1,700%)
  • Continued revenue and margin deterioration
  • High beta and volatility making the stock unsuitable for long‑term holding

Key Metrics & Analysis

Financial Health

Revenue Growth-15.80%
Profit Margin-38.41%
Debt/Equity1758.78
P/B Ratio1.1
Industry P/E16.9

Technical Analysis

TrendBearish
RSI44.8
Support$5.35
Resistance$7.26
MA 20$6.13
MA 50$6.20
MA 200$10.63
MACDBullish
VolumeDecreasing
Fear & Greed Index87.64

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.51
Volatility148.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.